Warren Stone - 01 Dec 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: President, Clinical Services
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 01 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 05 Dec 2023, 16:49:27 UTC
Previous filing: 15 May 2023
Next filing: 27 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-5,431	-6.1%	$0.000000	83,775	01 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						166,113	01 Dec 2023	Common Stock	166,113	$11.21	Direct	F2
holding	NEO	Stock Option (Right to Buy)						53,969	01 Dec 2023	Common Stock	53,969	$19.65	Direct	F3
holding	NEO	Restricted Stock Unit						28,838	01 Dec 2023	Common Stock	28,838	$0.000000	Direct	F4, F5
holding	NEO	Performance Stock Unit						21,204	01 Dec 2023	Common Stock	21,204	$0.000000	Direct	F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2023 vesting of restricted stock.
F2	On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3	On May 11, 2023, Mr. Stone was granted 53,969 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4	On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5	Once vested, the shares of common stock are not subject to expiration.
F6	On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.